![](/img/cover-not-exists.png)
Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer
Pedro T. Ramirez, Charles N. Landen Jr., Robert L. Coleman, Michael R. Milam, Charles Levenback, Taren A. Johnston, David M. GershensonVolume:
108
Year:
2008
Language:
english
Pages:
4
DOI:
10.1016/j.ygyno.2007.08.071
File:
PDF, 125 KB
english, 2008